Fred Alger Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-84,085
Closed -$1.53M 565
2021
Q4
$1.53M Buy
+84,085
New +$1.81M ﹤0.01% 373
2021
Q3
Sell
-3,057,808
Closed -$137M 580
2021
Q2
$137M Buy
3,057,808
+199,911
+7% +$9.27M 0.32% 105
2021
Q1
$144M Buy
2,857,897
+2,088,128
+271% +$142M 0.38% 90
2020
Q4
$68.8M Buy
769,769
+762,337
+10,257% +$64.1M 0.18% 135
2020
Q3
$568K Buy
+7,432
New +$472K ﹤0.01% 368

Other funds holding CELL

Fred Alger Management's CELL Position: Q1 2022 in Review

Fred Alger Management sold out of PhenomeX Inc. Common Stock (CELL) in Q1 2022, closing a stake of 84,085 shares — an estimated $1.53M sold.

Fred Alger Management first reported a position in CELL in Q3 2020 and held it in 5 quarters. The position peaked at $144M in Q1 2021. 130 funds tracked by Wall St. Rank hold CELL as of Q1 2022.

  • Fred Alger Management reported no remaining PhenomeX Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Fred Alger Management sold 84,085 PhenomeX Inc. Common Stock shares in Q1 2022, an estimated $1.53M.
  • Fred Alger Management first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 5 quarters.
  • Fred Alger Management's PhenomeX Inc. Common Stock position peaked at $144M in Q1 2021.
  • 130 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q1 2022.

Based on Fred Alger Management's 13F filing for Q1 2022, filed 16 May 2022.